The Pennant Group (NASDAQ:PNTG) Delivers Strong Q2 CY2026 Numbers, Full

The Pennant Group (NASDAQ:PNTG) reported Q2 CY2026 revenue of $298 million, up 37.3% year over year, exceeding Wall Street estimates by 3.2%. Full-year revenue guidance was $1.18 billion at the midpoint, 1.3% above estimates. Non-GAAP EPS was $0.36, up from $0.27 and 9.1% above consensus.

Original reporting
Published Aug 5, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 9:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
The Pennant Group (NASDAQ:PNTG) Delivers Strong Q2 CY2026 Numbers, Full — source image
Decision brief

The 30-second read

$PNTGBullishMed
01

Why it matters

Q2 results and full-year revenue guidance modestly above consensus can re-rate near-term expectations, but the expected deceleration and stable margins temper the earnings-quality and valuation upside.

02

Market read

Traders can use the reported beats and guidance midpoint to reassess near-term estimates, while monitoring the implied deceleration in revenue growth.

03

What to watch

Adjusted operating margin is only 6.8% and in line with last year, while EPS growth is partly offset by share dilution, which may matter for per-share valuation.

Relevance 8/10Novelty 6/10Timing: after-hours/posted Aug 5, following Q2 CY2026 results and full-year guidance

Background

Pennant Group is a senior living provider operating home health, hospice, and senior living facilities across 13 western and midwestern states.

Company-level read

Ticker impact

$PNTGBullishMedium confidence
Context

Pennant Group beat Q2 CY2026 revenue expectations, with sales up 37.3% to $298M and full-year revenue guidance slightly above estimates.

Expected impact

Likely near-term support for the stock versus peers, with upside capped if investors focus on the guided deceleration.

Evidence & confidence

The text provides concrete beats (revenue, EPS) and a guidance midpoint that is only 1.3% above estimates, plus a stated deceleration in expected revenue growth and stable adjusted operating margin.

Market effects

Reinforces demand and pricing strength in senior living/home health, but margin stability suggests limited operating leverage upside.

No specific regional read-through beyond its footprint in western and midwestern states.

Limited, as it is a US-focused healthcare provider with no cross-border catalyst described.

Counterpoint

The guidance beat is small and the article highlights expected revenue growth deceleration, which can limit multiple expansion even after a strong quarter.

Key entities

  • The Pennant Group

    Senior living provider reporting Q2 CY2026 revenue and EPS beats and full-year revenue guidance.

  • Brent Guerisoli

    CEO quoted saying the company is on pace to exceed the top end of original full-year guidance.

Related articles

$NHPLow

Senior Living Dealbook: Senior Living Residences Partners with RiverGlade Capital; BWE Arranges $101M Loan

Senior Living Residences partnered with RiverGlade Capital to aid growth. National Healthcare Properties (NHP) bought a 200-unit Florida community. Pennant Group (PNTG) acquired Mainplace Senior Living. Various senior living communities were sold, including a 173-unit near Manhattan. BWE arranged a $101M loan for a Florida community. Berkadia secured $39M in HUD financing for four communities. CFG closed $413M in 24 transactions. JLL closed $21M financing for a Georgia community.

$PNTGMed

Pennant Group Inc (PNTG) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth

Pennant Group Inc (PNTG) discussed Q2 2026 earnings call topics including integration of Metasys assets in the Southeast, raised full-year guidance, and improved same-store margins. Management cited above-guided organic growth in home health and hospice, about $1.3 million Medicare hospice cap liability, and operating cash flow on track for up to $58 million. CFO said 2026 CapEx is $15-17 million tied to late-2025 distressed senior living acquisitions.

$PNTGHigh

Pennant Group, Inc. (PNTG): Results of Operations and Financial Condition

Pennant Group, Inc. (PNTG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Pennant Reports Second Quarter 2026 Results Conference Call and Webcast scheduled for tomorrow, August 6, 2026 at 10:00 am MT EAGLE, Idaho – August 5, 2026 (GLOBE NEWSWIRE) - The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliate

$TSLAHighAI 9/10

Tesla Posted Negative $1.1 Billion in Free Cash Flow Last Quarter as Elon Musk Ramps Up Spending on Robotaxis and Optimus. Here's Why the Company's $43.5 Billion Cash Cushion Still Matters.

Tesla reported a 26% revenue increase to $22.5B in Q2, with net income of $1.11B, but negative free cash flow of $1.1B due to $5.79B in capital expenditures. The company's $43.5B cash position provides a buffer for growth investments in robotaxis, Optimus robots, and semiconductors. Tesla's market share in U.S. EVs has risen despite industry contraction, but competition from Chinese rivals like BYD persists.

$BWINMed

Michael Dell Just Made a $7.7 Billion Bet on This Insurance Stock

Michael Dell is acquiring Baldwin & Co. (BWIN) for $7.7B. Baldwin reported Q2 revenue of $492.9M (+30% YoY), adjusted net income of $68.5M, and adjusted EBITDA of $116.7M (+37%). Management guided Q3 revenue to $485M-$495M and full-year revenue to $2.01B-$2.05B. Analysts have mixed targets, with a consensus 'Moderate Buy' and average target of $33.